A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

NCT07159828 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early due to discontinuation of development of the investigational program.

Conditions

Interventions

Sponsor

Axion Bio, Inc

Collaborators